Related Experiment Video
Updated: Apr 8, 2026

Renal Ischaemia Reperfusion Injury: A Mouse Model of Injury and Regeneration
Published on: June 7, 2014
Update on ischemia-reperfusion injury in kidney transplantation: Pathogenesis and treatment
Maurizio Salvadori1, Giuseppina Rosso1, Elisabetta Bertoni1
1Maurizio Salvadori, Elisabetta Bertoni, Department of Renal Transplantation, Careggi University Hospital, 50139 Florence, Italy.
Abstract:
Ischemia/reperfusion injury is an unavoidable relevant consequence after kidney transplantation and influences short term as well as long-term graft outcome. Clinically ischemia/reperfusion injury is associated with delayed graft function, graft rejection, chronic rejection and chronic graft dysfunction. Ischemia/reperfusion affects many regulatory systems at the cellular level as well as in the renal tissue that result in a distinct inflammatory reaction of the kidney graft. Underlying factors of ischemia reperfusion include energy metabolism, cellular changes of the mitochondria and cellular membranes, initiation of different forms of cell death-like apoptosis and necrosis together with a recently discovered mixed form termed necroptosis. Chemokines and cytokines together with other factors promote the inflammatory response leading to activation of the innate immune system as well as the adaptive immune system. If the inflammatory reaction continues within the graft tissue, a progressive interstitial fibrosis develops that impacts long-term graft outcome. It is of particular importance in kidney transplantation to understand the underlying mechanisms and effects of ischemia/reperfusion on the graft as this knowledge also opens strategies to prevent or treat ischemia/reperfusion injury after transplantation in order to improve graft outcome.
Insights
Kidney transplant ischemia/reperfusion injury causes delayed function and rejection. Understanding its inflammatory mechanisms is key to developing treatments that improve long-term kidney graft survival.
Area of Science:
- Nephrology
- Transplantation Immunology
- Cellular Biology
Background:
- Ischemia/reperfusion (I/R) injury is a significant complication following kidney transplantation.
- It negatively impacts both short-term graft function and long-term outcomes, including delayed graft function, rejection, and chronic dysfunction.
- I/R injury triggers complex cellular and molecular inflammatory responses within the kidney graft.
Purpose of the Study:
- To elucidate the mechanisms underlying ischemia/reperfusion injury in kidney transplantation.
- To understand the cellular and molecular pathways involved in the inflammatory cascade.
- To identify potential therapeutic targets for mitigating I/R injury and improving graft survival.
Main Methods:
- Review of existing literature on ischemia/reperfusion injury in kidney transplantation.
- Analysis of cellular mechanisms including energy metabolism, mitochondrial dysfunction, and cell death pathways (apoptosis, necrosis, necroptosis).
- Examination of the role of inflammatory mediators like chemokines and cytokines in activating innate and adaptive immunity.
Main Results:
- Ischemia/reperfusion injury involves disruptions in cellular energy metabolism and mitochondrial function.
- Diverse cell death pathways, including apoptosis, necrosis, and necroptosis, are activated.
- Inflammatory mediators drive immune system activation, potentially leading to interstitial fibrosis and chronic graft dysfunction.
Conclusions:
- Understanding the intricate mechanisms of I/R injury is crucial for kidney transplantation.
- Targeting inflammatory pathways and cellular damage could offer strategies to prevent or treat I/R injury.
- Improving management of I/R injury is essential for enhancing long-term kidney graft outcomes.
Related Concept Videos
Kidney Transplant II: Surgical Procedure
Acute Kidney Injury II: Pathophysiology
Kidney Transplant I: Introduction
Acute Kidney Injury I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Kidney Transplant III: Nursing Management

